SGT-263

We are pleased to welcome you to our online shop, where we offer a wide range of research chemicals to help the scientific community in its pursuit of knowledge. This guide introduces SGT-263 a synthetic cannabinoid that has a lot of research potential. This article will provide essential information on SGT-263 including its development and chemical properties as well as its uses, effects, dosage, and recommended use.

Development and Background

SGT-263 is a synthetic cannabinoid that belongs to the SGT series. It has attracted the attention of researchers because of its affinity for CB1 and CB2 receptors. SGT-263 was developed as part of ongoing efforts in order to create novel, potent agonists of these receptors. This allows scientists to delve further into the complex pharmacology and endocannabinoid systems.

CAS Number and Chemical name

SGT-263 has the CAS number 1971007-95-0. This is a unique identifier in scientific databases. The IUPAC (International Union of Pure and Applied Chemistry) name for SGT-263 is N-(2-phenylpropan-2-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide. This name provides researchers with a standard reference and describes the chemical structure of the compound.

Molecular Formula

SGT-263’s molecular formula is C23H27FN2O. This means that it consists 23 carbon atoms and 27 hydrogen atoms. It also contains one fluorine, two nitrogen, and one oxygen. Its molecular mass is 366.48g/mol.

Compound Color and Shape

SGT-263 can be found as a powdery white or off-white crystal. This powder ensures that it dissolves in different solvents and can be used in many experimental settings. Store the compound in a dry, cool place, away from heat or direct sunlight, to preserve its stability.

Uses and effects of SGT-263

SGT-263 has not been approved for medical or human use, but it is a useful research tool for scientists who are studying the endocannabinoid systems and possible therapeutic applications of synthetic cannabis. SGT-263 is a potent agonist for the CB1-CB2-receptors and exhibits a variety of effects similar to those produced by naturally occurring cannabinoids such as THC. These effects may include feelings of euphoria and relaxation, altered perceptions, or increased appetite. SGT-263’s potency and novel structure may produce unexpected or unwanted effects.

Dosage and precautions

SGT-263, a research chemical that is not meant for human consumption is to be handled with extreme care. Researchers who work with SGT-263 must adhere to strict safety protocol, including using personal protective equipment (PPE) and proper ventilation.

SGT-263 dosage should be determined carefully based on the study objectives and conditions of experimental research. When designing experiments, researchers must consider the compound’s potency as well as its potential for adverse side effects.

The conclusion of the article is:

SGT-263 has a high research potential and is a potent, promising synthetic cannabinoid. Its unique chemical composition and affinity for CB1- and CB2-receptors makes it a great candidate for scientific exploration. Researchers are continuing to discover new insights about the endocannabinoid and potential therapeutic applications for synthetic cannabinoids such as SGT-263. It is important to approach research with utmost responsibility and care.